Dual targeting of BTK and BCL2 enhances apoptosis in marginal zone lymphoma models: preclinical activity of BGB-16673 and sonrotoclax
Alberto J. Arribas, Elisa Civanelli, Camilla Scalise, Luciano Cascione, Andrea Rinaldi, Davide Rossi, Emanuele Zucca, Laura Carosella, Stefano Raniolo, Vittorio Limongelli, Francesco Bertoni
This study evaluates the preclinical efficacy of BGB-16673 and sonrotoclax in marginal zone lymphoma models, showing enhanced apoptosis when combined.
bioRxiv · Nov 24, 2025 · PreprintCancer Biology